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Oligodendrocyte precursor cells (OPCs) give rise to oligodendrocytes which myelinate axons in 
the central nervous system (CNS). Although classically thought to be a homogeneous population, 
OPCs are reported to have different developmental origins and display regional and temporal 
diversity in their transcriptome, response to growth factors, and physiological properties. 
Similarly, evidence is accumulating that myelinating oligodendrocytes display transcriptional 
heterogeneity. Analysing this reported heterogeneity suggests that OPCs, and perhaps also 
myelinating oligodendrocytes, may exist in different functional cell states. Here, we review the 
evidence indicating that OPCs and oligodendrocytes are diverse, and we discuss the implications 




Myelin is a lipid-rich membrane compactly wrapped around axons that allows for rapid electrical 
conduction and input synchronization (Pajevic and others 2014). The importance of myelin 
becomes clear with the severe motor and cognitive symptoms observed in dysmyelinating 
disorders such as multiple sclerosis or leukodystrophies. In the central nervous system (CNS), 
oligodendrocytes produce myelin and provide metabolic support to the axons through the myelin 
sheath (Nave 2010). During development, oligodendrocytes arise from oligodendrocyte precursor 
cells (OPCs), and this capacity for differentiation continues into adulthood. However, in the adult, 
OPCs differentiate at a much lower rate than in development, making their abundance and even 
distribution in the adult brain enigmatic (Dawson and others 2003; Rivers and others 2008). Thus, 
it has been postulated that they are a unique cell type, the fourth glial cell, with functions beyond 
that of oligodendrocyte precursors, including interacting with the vasculature, modulating 
neuroinflammation and modulating neuronal synaptic signalling (Pepper and others 2018). 
However, the clearest role of adult OPCs remains differentiating into myelinating 
oligodendrocytes, which is critical for both myelin repair and learning (Tripathi and others 2010; 
McKenzie and others 2014; Pan and others 2020; Steadman and others 2020; Wang and others 
2020). Both OPCs and oligodendrocytes express several ion channels and neurotransmitter 
receptors (Larson and others 2016; Marinelli and others 2016), making them sensitive to neuronal 
activity, which has been shown to modulate OPC proliferation and differentiation and 
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oligodendrocyte myelination, and may therefore underlie learning-evoked myelination (Barres and 
Raff 1993; Gibson and others 2014; Mitew and others 2018). However, emerging evidence 
suggests that OPCs and oligodendrocytes may exhibit diversity in their sensitivity to neuronal 
activity, and other regulatory cues, which may have implications for our understanding of myelin 
repair and learning. Thus, here we review the evidence for OPC and oligodendrocyte diversity, 
propose that this evidence points to functional cell states, and examine the implications of OPC 
states for myelin repair and adult myelination. 
 
 
Oligodendrocyte precursor cell diversity 
OPCs are typically identified by morphology, a combination of antigens, and specific membrane 
properties (Figure 1). Early work discovered that these cells are labelled by antibodies against 
PDGFRα and NG2 (Nishiyama and others 1996). OPCs are also positive for OLIG2 and SOX10, 
two common markers for oligodendrocyte lineage cells. Electrophysiological studies defined 
OPCs as cells with fast tetrodotoxin-sensitive voltage-gated sodium channels, outwardly rectifying 
fast and delayed voltage-gated potassium channels, and lacking the tail currents typical of 
differentiated oligodendrocytes (Figure 1) (Sontheimer and others 1989; Berger and others 1991; 
Kettenmann and others 1991; Agathou and Káradóttir 2019). Further, OPCs were found to express 
AMPA/kainate receptors, and some express NMDA receptors, yet their utility as defining features 
remains unclear (Barres and others 1990; Berger and others 1992; Wang and others 1996; 
Karadottir and others 2005; De Biase and others 2010; Spitzer and others 2019). Therefore, 
antigens remain the gold standard by which to identify OPCs. 
 
An increasing body of literature suggests that OPCs are diverse at the transcriptomic and functional 
level. This diversity may stem from the generation of OPCs in three spatially and temporally 
segregated developmental waves (Kessaris and others 2006). Using a Cre-lox approach, OPCs 
derived from these three waves can initially be identified by different transcription factors (first 
wave: Nkx2.1; second wave: Gsh2; third wave: Emx1), although they are all positive for NG2 and 
PDGFRα and are physiologically, transcriptionally and functionally homogeneous (Kessaris and 
others 2006; Psachoulia and others 2009; Tripathi and others 2011; Marques and others 2018). 
Intriguingly, RNA from the transcription factors corresponding to the second and third waves can 
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still be found postnatally in cortical OPCs (Zhang and others 2014; Marques and others 2018; 
Spitzer and others 2019). Nevertheless, both temporal and regional heterogeneity is observed in 
the OPC transcriptome (Lin and others 2009; Marques and others 2016; Marques and others 2018; 
Neumann and others 2019; Spitzer and others 2019; Ximerakis and others 2019; Marisca and 
others 2020), and the OPC proteome alters with age (de la Fuente and others 2020). Numerous 
studies also report diversity in OPC bioelectrical properties and neurotransmitter receptors 
(Blankenfeld and others 1992; Borges and others 1995; Rogers and others 2001; Chittajallu and 
others 2004; Ziskin and others 2007; Karadottir and others 2008; Karram and others 2008; Vélez-
Fort and others 2009; Vélez-Fort and others 2010; Maldonado and others 2013; Balia and others 
2015; Moshrefi-Ravasdjani and others 2017; Marques and others 2018; Spitzer and others 2019), 
although this is disputed (De Biase and others 2010; Kukley and others 2010; Clarke and others 
2012). Recently, we found that while OPCs appear in the forebrain as a homogeneous population 
lacking ion channels and glutamate receptors, they gradually acquire these with age, at different 
rates (Figure 2), and become physiologically heterogeneous between and within postnatal brain 
regions (Spitzer and others 2019), which may partially explain previous differing observations. 
 
A small number of antigens including PLP, ASCL1, BCAS1 or GPR17 label subpopulations of 
OPCs, although their relation to the transcriptome or physiology is unclear (Mallon and others 
2002; Parras and others 2007; Boda and others 2011; Fard and others 2017). Nonetheless, 
functional differences are described between OPCs that are antigenically indistinguishable. 
Proliferation and differentiation rates are lower in aged versus neonatal OPCs, and higher in white 
matter than grey matter OPCs (Wolswijk and Noble 1989; Shi and others 1998; Rivers and others 
2008; Lin and others 2009; Psachoulia and others 2009; Clarke and others 2012; Viganò and others 
2013; Young and others 2013; Moshrefi-Ravasdjani and others 2017; Spitzer and others 2019). 
These differences may partially be explained by the differential responses to growth factors and 
cytokines that occur with ageing and between brain regions (Chan and others 1990; Mason and 
Goldman 2002; Lin and others 2009; Hill and others 2013; Lentferink and others 2018; Neumann 
and others 2019). 
 
These data indicate that OPCs are a diverse population. It is currently debated whether this 
diversity represents heterogeneity or cell plasticity (see reviews by Dimou and Simons 2017, and 
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Foerster and others 2019). To define heterogeneity, we can look beyond OPCs, for example to 
GABAergic interneurons. These are a group of heterogeneous cells, each with a distinct subtype 
defined by a specific morphology, antigen(s), transcriptome, physiology, connectivity, and 
therefore, function (Lim and others 2018). This definition is difficult to apply to OPCs, as their 
diversity is poorly understood, and it is unclear how the observed range of transcriptomic, 
physiological, antigenic and functional properties relate to each other. Further, age-driven changes 
in the same NG2/PDGFRα positive population suggest a more dynamic system. In fact, 
transplantation studies indicate that OPC diversity is not solely determined by specific regional 
subtypes, as for GABAergic neurons, nor is it determined solely by the environment (Viganò and 
others 2013). These studies indicate that OPC diversity is more complex, and may not be fully 
explained by either distinct cell subtypes (i.e. true cell heterogeneity) or exclusive environmental 
regulation (i.e. where all cells, regardless of origin, exhibit the same phenotype when exposed to 
the same environment) but may rather be explained by a dynamic mixture of the two. In cell 
biology, it is known that often the same cell population, with a stable cell identity, can exist in 
multiple states and thus the same cell can exhibit different phenotypes, which may be associated 
with a molecular profile and function, that often depend on external cues (Morris 2019). Drawing 
from other fields such as stem cell biology, cancer, and immunology, we propose that OPCs can 
be found in the following functional states: naïve, migratory, highly proliferative, primed, 




The naïve cell state 
A naïve cell state is a state where a cell is unconditioned or unstimulated by environmental factors 
that induce it to a specific path or function – a blank slate. The naïve state can be identified by a 
distinct molecular signature. Do OPCs, which are often thought to be homogeneous, exhibit a 
naïve cell state, as is common amongst progenitors, stem cells and other cell types with specific 
functional states? To determine the naïve state, it is best to examine early development, specifically 
when the cells are first born or appear. OPCs first appear in the medial ganglionic eminence and 
anterior entopeduncular area of the forebrain at E12.5 and distribute throughout the forebrain. 
Transcriptional studies and functional single-cell electrophysiological studies show that these early 
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born OPCs are distinct from cells found later in development. PDGFRα positive E13 cells express 
lower transcript levels of genes associated with oligodendrocyte differentiation, growth factor 
binding, ion channels, glutamate receptors, and synaptic activity compared to postnatal OPCs, but 
have a higher expression of genes associated with cell cycling, neural progenitors, transcription 
factor activity, and the cytoskeleton (Marques and others 2018). These findings are reproduced in 
human foetal tissue, where a distinct population of PDGFRα positive cells was identified (Huang 
and others 2020; Perlman and others 2020). This population expresses a number of neural 
progenitor genes, and is marked by EGFR expression, which is also highly expressed in E13 
murine PDGFRα positive cells (Marques and others 2018; Huang and others 2020). At a functional 
level, we found that NG2 positive E13 cells lack sodium and potassium voltage-gated ion channels, 
as well as glutamate receptors, which are classical hallmarks of postnatal OPCs (Figure 2) (Spitzer 
and others 2019). Thus, low levels of growth factor or cytokine receptors, and the absence of ion 
channels and glutamate receptors suggest that these E13 OPCs may lack the apparatus to respond 
to extracellular cues driving proliferation or differentiation, such as growth factor signalling or 
neuronal activity, and that this distinct molecular and physiological signature may define the naïve 
OPC state (Figure 3). 
 
Naïve OPCs (lacking glutamate receptors and voltage-gated ion channels) are observed at all ages 
and in all brain regions; however, they are a minority of OPCs in postnatal timepoints (Figure 4) 
(Spitzer and others 2019). Thus, as these cells are mostly restricted to embryonic timepoints, this 
profile may be characteristic of OPCs generated in the first developmental wave and may therefore 
represent a cell subtype rather than a cell state (Kessaris and others 2006). However, analysis of 
the transcriptome and physiology of OPCs derived from the first and third waves shows that they 
do not differ postnatally (Marques and others 2018). In addition, OPCs derived from the first wave 
account for approximately 95% of callosal OPCs at P0 (Kessaris and others 2006), while naïve 
OPCs represent less than 1% (Spitzer and others 2019), and cannot be detected by sequencing in 
neonates (perhaps due to differing sensitivity of RNA sequencing and single-cell 
electrophysiological recordings) (Marques and others 2018). Further, although OPCs derived from 
the first wave disappear from the adult cortex and corpus callosum, naïve OPCs are occasionally 
observed in these and other regions; in fact, postnatally, the highest proportion of these OPCs is 
found in the dorsal subventricular zone (Spitzer and others 2019) where OPCs from the first wave 
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or Nkx2.1 progenitors are hardly detected (Kessaris and others 2006; Young and others 2007). 
These data suggest that while all E13 OPCs are naïve, naïve OPCs persist in the postnatal brain, 
possess a unique transcriptional and physiological profile, and may represent a cell state rather 
than origin-derived heterogeneity. 
 
 
The migratory cell state 
A migratory cell state is a state of rapid and substantial migration, often occurring when a cell 
population generated in a defined domain migrates to populate a larger region. The migratory state 
can be difficult to distinguish from a highly proliferative state, as migration and population 
expansion often occur simultaneously. However, a migratory state would exhibit a specific 
molecular signature characterised by an upregulation of migratory and cytoskeletal genes. During 
development, OPCs initially appear in the ventral forebrain and migrate into the dorsal forebrain, 
and in adults, OPCs rapidly migrate into demyelinating or acute lesions, suggesting that they may 
exhibit a migratory state (Franklin and others 1997; Dimou and Gallo 2015). Thus, examining 
OPCs immediately after injury or while cells generated ventrally migrate into the dorsal brain may 
allow us to examine the potential of a migratory state. 
 
While limited data exist, OPCs at E16 express high levels of migration, axon guidance, and 
cytoskeletal genes (Spitzer and others 2019). Further, single-cell sequencing of a small number of 
E17.5 PDGFRα positive cells indicates that they begin to exhibit diversity in their transcriptome, 
clustering with both E13 and neonatal OPCs (Marques and others 2018). Electrophysiological 
studies find that voltage-gated potassium channels and AMPA/kainate receptors are first detected 
in E18 OPCs (Figure 2D), and are unlikely to reflect the establishment of the second developmental 
wave, which does not differ physiologically from the other waves (Tripathi and others 2011; 
Spitzer and others 2019). Both voltage-gated potassium channels and AMPA/kainate signalling 
promote OPC migration (Wang and others 1996; Gudz and others 2006; Tiwari-Woodruff and 
others 2006; Harlow and others 2015). Notably, during the recruitment phase (OPC migration and 
proliferation) following a toxin-induced demyelinating lesion, only AMPA/kainate currents are 
detected (Gautier and others 2015). Taken together, these data suggest that OPCs may exhibit a 
migratory state, marked by a distinct transcriptome and physiology (Figure 3). However, 
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potassium channels and AMPA/kainate signalling are also thought to regulate OPC proliferation 
(Yuan and others 1998; Ghiani and others 1999; Chittajallu and others 2002; Vautier and others 
2004; Fannon and others 2015), and thus, whether this distinct transcriptional and physiological 
profile represents a distinct migratory state, or rather a transition point between the naïve and 
highly proliferative states remains to be determined. 
 
 
The highly proliferative cell state 
In proliferative cells, a rapid proliferation state differs from slower baseline growth, and is a state 
of rapid cell growth, occurring when expansion of the cell population is needed. This state is 
transcriptionally and functionally different from other states of that same cell. The ability to 
proliferate is one of the essential characteristics of OPCs. However, like most stem cells, the 
proliferation rate varies in OPCs, with rapid OPC proliferation occurring after acute or 
demyelinating injuries in the adult (Levine and Reynolds 1999; Dimou and Gallo 2015) or regional 
differences during normal brain homeostasis, indicating that OPCs may exhibit a proliferative 
state, where they show rapid turnover. The strongest evidence comes from studies comparing 
different brain regions, where white matter OPCs cycle faster than grey matter OPCs, and exhibit 
a stronger response to the mitogen PDGF (Psachoulia and others 2009; Clarke and others 2012; 
Hill and others 2013; Young and others 2013; Spitzer and others 2019), although Viganò and 
others (2013) report no differences in proliferation rate between grey and white matter OPCs 
following transplantation. With age however, proliferation dramatically decreases as a result of 
cell cycle time lengthening (Wolswijk and Noble 1989; Shi and others 1998; Lin and others 2009; 
Psachoulia and others 2009; Young and others 2013; Marques and others 2016; Moshrefi-
Ravasdjani and others 2017; Spitzer and others 2019). Thus, whether OPCs exhibit a proliferative 
cell state, and what its hallmarks may be, can be determined during early development, or 
following injury to the CNS, when it is known that the OPC population is expanding. 
 
Transcriptional studies reveal a distinct population of cycling OPCs, mostly detected in neonates, 
during the peak of proliferation, and enriched in cell cycle and proliferation genes (Marques and 
others 2018). Similarly, a cluster of highly proliferative OPCs is detected in human foetal tissue, 
coinciding with population expansion (Huang and others 2020). These data indicate that while 
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OPCs cycle throughout life, a population of highly proliferative cells congregates during early 
development (Young and others 2013; Marques and others 2018; Spitzer and others 2019; 
Ximerakis and others 2019; Huang and others 2020). Electrophysiological studies show that at the 
same timepoint, the density of voltage-gated sodium channels peaks in NG2 positive cells (Figure 
2A), and recordings in KI67-RFP or FUCCI2a reporter mice (which mark actively cycling cells) 
show that proliferating OPCs have a higher density of voltage-gated sodium channels (Spitzer and 
others 2019). Further, three days after global cerebral ischemia, at the peak of proliferation, 
hippocampal OPCs increase their outward voltage-gated potassium channel densities (Pivonkova 
and others 2010). Thus, these data indicate that there is a highly proliferative population of 
PDGFRα and NG2 positive OPCs with a distinct transcriptomic and physiological profile, as well 
as a distinct function, suggesting that it is representative of a cell state (Figure 3). 
 
How voltage-gated sodium channels may regulate OPC proliferation is unclear, but they have been 
implicated in the proliferation of cancer cell lines, retinal ganglion cell precursors, and astrocytes 
(Pereira and Araujo 1997; MacFarlane and Sontheimer 2000; Anderson and others 2003). In 
addition, depolarized cells proliferate more than hyperpolarized cells (Binggeli and Weinstein 
1986), and sodium channels modulate the resting membrane potential in OPCs (Xie and others 
2007). Further, cells with high sodium channel densities would have increased sensitivity to 
neuronal activity, which promotes proliferation (Barres and Raff 1993; Gibson and others 2014; 
Mitew and others 2018). However, increasing intracellular sodium with kainate or veratridine 
(which prevents voltage-gated sodium channel inactivation) decreases OPC proliferation by 
blocking outward potassium currents, which regulate cell cycle progression, and have been shown 
to be regulated by PDGF signalling (Knutson and others 1997; Ghiani and others 1999; Chittajallu 
and others 2002; Vautier and others 2004; Chittajallu and others 2005). Thus, rather than promote 
proliferation, the onset of high densities of sodium channels could in fact downregulate 
proliferation and promote transition into another cell state. 
 
 
The primed cell state  
A primed cell state is a state between cell growth and rapid effector function in which cells are 
primed/poised to differentiate. The primed cell state is achieved when cells are exposed to the 
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more complex microenvironmental cues that initiate differentiation potential and is reflected by 
specific primed signatures. In the forebrain, the rate of myelination peaks in the first postnatal 
month, but varies between regions (Hamano and others 1998). In line with this, OPCs display 
temporal and regional differences in differentiation potential. For instance, white matter OPCs 
differentiate at a higher rate than grey matter OPCs and aged OPCs have reduced differentiation 
potential (Wolswijk and Noble 1989; Rivers and others 2008; Viganò and others 2013; Young and 
others 2013; Neumann and others 2019). Thus, analysing OPCs during the peak of myelination 
provides the potential to determine the OPC primed state. 
 
Bulk sequencing OPCs during this timepoint shows that they upregulate genes involved in 
differentiation, signal transduction, synaptic signalling, ion transport, and glutamate receptors 
(Marques and others 2018; Spitzer and others 2019). Single-cell sequencing studies detect a 
population of neonatal OPCs distinct from cycling, embryonic and adult OPCs. This cluster is 
similar enough to the adult OPC cluster to likely represent a cell state rather than a cell type 
(Marques and others 2018). In human tissue, OPCs analysed during the peak of myelination 
upregulate genes related to cholesterol metabolism, cell adhesion and extracellular matrix 
composition, all essential markers of myelination, compared to adult OPCs, indicating that these 
OPCs are primed to differentiate and myelinate (Perlman and others 2020). Electrophysiological 
recordings from OPCs during the peak in differentiation and myelination show that the proportion 
of OPCs with NMDA receptors and the density of NMDA receptors are highest in this timepoint, 
alongside a high density of voltage-gated sodium channels, and are particularly high in the white 
matter, where myelination occurs at a higher rate (Spitzer and others 2019), and in demyelinating 
lesions at the time OPCs start to differentiate (Gautier and others 2015). Further, NMDA receptors 
are absent from aged OPCs, which have reduced differentiation potential (Figure 2). Since OPCs 
with NMDA receptors seem to be primed for differentiation, it could be proposed that they are 
early differentiated oligodendrocytes. However, the fact that these cells still proliferate argues 
more strongly for this being a specific OPC state (Spitzer and others 2019). Together, these data 
suggest that there may be a population of OPCs, identifiable by a transcriptional profile and 
NMDA receptor expression, that are in a primed state (Figure 3). As primed OPCs are still 
proliferative cells, they potentially can either undergo proliferation prior to differentiation or 
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directly differentiate; current evidence supports both possibilities (Hughes and others 2013, Hill 
and others 2014; Bacmeister and others 2020). 
 
In myelinating oligodendrocytes, NMDA receptor signalling is thought to regulate glucose import 
(Saab and others 2016). Perhaps primed OPCs upregulate NMDA receptors to provide energy in 
preparation for differentiation. Intriguingly, this cell population is marked by increased metabolic 
activity genes (Marques and others 2018; Spitzer and others 2019). Although NMDA receptor 
knockouts appear to have little effect on myelination (De Biase and others 2011; Guo and others 
2012; Saab and others 2016), blocking NMDA signalling in the young adult prevents myelin 
regeneration after a toxin-induced demyelinating lesion (Lundgaard and others 2013). The 
discrepancies between the knockout and drug studies may stem from the fact that NMDA receptors 
are knocked out prior to their upregulation, preventing the switch to the activity- and NMDA-
dependent mode of myelination, as the switch is dependent on NMDA receptor activation 
(Lundgaard and others 2013). Nonetheless, the concomitance of NMDA receptor expression with 
the peak of myelination suggests that it may identify the primed state, although it is likely to be 
one of many markers for this cellular state. 
 
 
The quiescent cell state 
Quiescence is a state in which a cell reversibly enters G0 (or an extended G1), with the potential 
to re-enter the cell cycle upon stimulation. Most quiescent stem cells or progenitors share a 
common pattern of gene expression, including the downregulation of cell cycle and metabolic 
genes (Cheung and Rando 2013). Quiescence differs from senescence, where cells have 
irreversibly exited the cell cycle. To determine whether OPCs potentially show a quiescent cell 
state, we reviewed the literature on functional changes in OPCs with age, as in most other tissues 
the quiescent cell state is more common in older animals. 
 
OPCs in the mature CNS are characterised by a decrease in proliferation as the cell cycle lengthens 
(Wolswijk and Noble 1989; Shi and others 1998; Rivers and others 2008; Lin and others 2009; 
Psachoulia and others 2009; Young and others 2013; Marques and others 2016; Moshrefi-
Ravasdjani and others 2017; Spitzer and others 2019). Further, the transcriptome and proteome of 
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aged OPCs show decreased cell cycle genes and proteins, decreased metabolic processes, and an 
increased quiescent signature (Cheung and Rando 2013; Neumann and others 2019; Spitzer and 
others 2019; de la Fuente and others 2020).  
 
Quiescence is a reversible state. Are the changes in OPCs reversible? Following a demyelinating 
injury, adult OPCs revert to a neonatal-like transcriptome (Moyon and others 2015). In addition, 
single-cell sequencing showed that OPCs isolated from mice with experimental autoimmune 
encephalomyelitis (EAE), a mouse model of the inflammatory component of multiple sclerosis, 
clustered separately from OPCs isolated from control mice, and upregulated proliferation and 
differentiation genes, perhaps indicating a shift from the quiescent state to proliferative and primed 
states in response to inflammation (Falcão and others 2018). Surprisingly, sequencing also 
identified a population of immunocompetent OPCs, expressing MHC II proteins and capable of 
phagocytosis (Falcão and others 2018; Kirby and others 2019). These OPCs may perhaps be 
observed with ageing, as immune response related genes, including MHC II related genes, increase 
in nine month old mice along with quiescence genes (Spitzer and others 2019). However, the 
function of these immunocompetent OPCs is currently unknown. Further, quiescence can be 
induced in human foetal OPCs, indicating that human OPCs also likely exhibit a reversible 
quiescent state (Wang and others 2018).  
 
With ageing, the physiological properties of OPCs are also altered. OPCs show decreased voltage-
gated sodium channel densities, and acquire a high resting potassium conductance, which is 
associated with G1, perhaps indicating that aged OPCs are entering an extended G1 (Maldonado 
and others 2013; Urrego and others 2014). Further, aged OPCs are characterised by the loss of 
NMDA receptors, and a high AMPA/kainate receptor density (Figures 2, 3) (Spitzer and others 
2019). Of note, in this study, we applied kainate at a concentration that activates both AMPA and 
kainate receptors, and thus could not distinguish between the two; as kainate receptors have a 
higher single-channel conductance than AMPA receptors, the observed increase in AMPA/kainate 
receptor density could indicate a shift from AMPA to kainate signalling rather than an equivalent 
increase in receptor density, but this remains to be investigated. It is unclear why AMPA/kainate 
signalling increases with ageing, as some studies report that it blocks proliferation and 
differentiation (Yuan and others 1998; Fannon and others 2015), while constitutively knocking out 
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AMPA receptors leads to myelination defects (Kougioumtzidou and others 2017). However, 
altering AMPA receptor subunits during the peak of myelination differentially affects proliferation 
and differentiation, confirming the importance of AMPA signalling in vivo, and indicating that 
dynamic changes in receptor function are likely to modulate OPC proliferation and differentiation, 
supporting the idea of OPC functional states (Chen and others 2018). In addition, while the density 
of ion channels and glutamate receptors alter with age, their transcript levels remain stable 
postnatally, enabling rapid protein expression and membrane insertion, suggesting that adult OPCs 
are in a reversible G0 state or extended G1 state, and thus, represent the quiescent OPC state 
(Spitzer and others 2019). 
 
 
The senescent cell state 
Senescence is a state in which a cell has irreversibly exited the cell cycle and permanently entered 
G0. The senescent and quiescent states can be difficult to distinguish transcriptionally, as several 
molecular markers are expressed in both states, although senescence does have some unique 
markers (Terzi and others 2016). Senescent cells accumulate with age, and thus, identifying the 
existence of a senescent OPC is best done in aged animals (Van Deursen 2014). We previously 
reported genes associated with senescence in nine month old OPCs; however, these genes are more 
likely to be associated with quiescence (Cheung and Rando 2013; Beerman and others 2014; 
Spitzer and others 2019). In addition, we did not detect any changes in the transcript levels of 
genes only associated with senescence (Terzi and others 2016; Spitzer and others 2019). Markers 
typically associated with senescent cells such as increased Cdkn2a or decreased ribosomal 
biosynthesis have only been detected in OPCs from 20 month old animals (Terzi and others 2016; 
Lessard and others 2018; Neumann and others 2019; Ximerakis and others 2019). Thus, with 




Correlating data obtained from electrophysiology, transcriptomic and proteomic analyses, and cell 
function, we propose that OPCs can be found in different functional states. However, it is difficult 
to confirm that states identified by electrophysiology or sequencing are identical. For instance, 
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while we detected changes in ion channels and glutamate receptors at a functional level, we could 
not detect these changes in the transcriptome, indicating that these cell states may not be detected 
by sequencing alone, or that additional markers are needed (Spitzer and others 2019). Further, it 
remains unclear whether the distinct profiles described above are transient or permanent. Our 
electrophysiological data suggest somewhat transient profiles, as we observe varying proportions 
of each state at different timepoints, and in different brain regions, following function (Figure 4). 
However, individual single-cell sequencing studies have mostly been restricted to two timepoints 
and may therefore not capture the full range of possible cell states, or the progression between 
states, although human sequencing data collected at multiple timepoints appear to recapitulate the 
electrophysiological functional states (Perlman and others 2020). Interpreting transplantation, 
injury and long-term imaging studies from the viewpoint of the aforementioned states, it appears 
that OPCs can transition between states when exposed to a different environment or changes in 
neuronal activity, but are rather stable in a specific state when undisturbed in young adult animals 
(Hughes and others 2013, Viganò and others 2013; Hill and others 2014; Marisca and others 2020). 
Nonetheless, until precise and cohesive physiological, transcriptomic, proteomic and epigenetic 
profiles are defined, and found to be transient or fixed, these data remain correlative. Importantly, 





Oligodendrocytes are a major cell population in the human CNS (Salvesen and others 2017; 
Perlman and others 2020). While morphological diversity in mature oligodendrocytes was 
described in the early twentieth century, these cells are generally described as a functionally 
homogeneous population (del Rio-Hortega 1928; Bakiri and others 2011; Chong and others 2012). 
However, some evidence indicates that oligodendrocytes may preferentially myelinate specific 
axonal tracts or respond differently to myelination cues, suggesting that they display functional 
heterogeneity (Tripathi and others 2011; Bechler and others 2015; Osanai and others 2017). 
Furthermore, single-cell sequencing of adult oligodendrocytes in the somatosensory cortex and 
hippocampus identified six differentiated oligodendrocyte states ranging from newly differentiated 
to terminally differentiated (Zeisel and others 2015). One intermediate state was found mostly in 
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the somatosensory cortex, suggesting that it may represent a region-specific cell state, although it 
might also reflect the posterior-anterior progression of myelination (Flechsig 1901; Zeisel and 
others 2015). This finding was replicated in human tissue, where several mature oligodendrocyte 
states were identified (Jäkel and others 2019), although Perlman and others (2020) did not detect 
these subsets. Additional sequencing studies in multiple murine CNS regions identified six further 
states within the two myelinating and terminally differentiated states reported previously (Zeisel 
and others 2015; Marques and others 2016) (Figure 5), although these six states are not consistently 
detected between studies (Falcão and others 2018). The functional correlates of these states are 
unclear, but may represent different stages in myelination (Figure 6). For instance, clusters MOL1-
4 are enriched in lipid biosynthesis and myelination genes, suggesting that they are actively 
myelinating (Marques and others 2016). However, within this group, individual clusters show 
varying levels of enrichment for lipid synthesis, perhaps indicating different stages in the 
myelination process. In addition, one cluster, MOL3, was also enriched in synaptic genes, perhaps 
indicating that it is altering myelin thickness in response to neuronal activity at the axo-myelinic 
synapse (Micu and others 2006; Gibson and others 2014; Mitew and others 2018), or searching for 
new active neurons to myelinate (Hines and others 2015; Mensch and others 2015; Bacmeister and 
others 2020). Intriguingly, MOL3 is increased following EAE induction, perhaps indicating a 
contribution of myelinating oligodendrocytes to remyelination (Falcão and others 2018; 
Bacmeister and others 2020). Clusters MOL5 and MOL6 are enriched in synapse, actin-binding 
and actin cytoskeleton reorganization genes but may be more mature, as they have lower 
expression of genes driving myelination, compared to MOL1-4 (Marques and others 2016). Based 
on these differentially expressed genes, it is possible to postulate that clusters MOL5-6 may 
indicate cells actively undergoing sheath elongation or retraction induced by neuronal activity, as 
actin turnover drives myelin growth, and calcium signalling regulates internode elongation or 
retraction; thus, these cells may be engaged in myelin remodelling (Nawaz and others 2015; 
Baraban and others 2018; Hughes and others 2018; Krasnow and others 2018; Bacmeister and 
others 2020). Whether these profiles represent different cell types or different cell states is still 
unclear; nonetheless, identifying the function associated with each profile, and whether this 
function is transient, which would be indicative of states, or permanent, which would indicate cell 
types, will provide a better understanding of oligodendrocyte diversity. This may be particularly 
important in the context of multiple sclerosis, as the proportion of cells in individual 
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oligodendrocyte clusters is altered in both EAE and multiple sclerosis (Falcão and others 2018; 
Jäkel and others 2019, Schirmer and others 2019). 
 
 
Implications for myelination and myelin repair 
Activity-dependent myelination and cell states 
Neuronal activity regulates OPC proliferation and differentiation, as well as myelination (Barres 
and Raff 1993; Gibson and others 2014; Mitew and others 2018), likely through neurotransmitter 
signalling, glutamate in particular, and growth factor signalling (Lundgaard and others 2013; 
Geraghty and others 2019, Swire and others 2019). However, in vitro, oligodendrocytes can 
myelinate inert fibres, indicating that myelination can proceed independent of activity (Lee and 
others 2012; Bechler and others 2015). We previously showed that there are two modes of 
myelination: a neuronal activity- and NMDA receptor-dependent mode, and an activity-
independent mode. Activity-dependent release of neuregulin (NRG), or BDNF, and 
simultaneously glutamate, switches myelination from an activity-independent mode to an activity-
dependent mode, where the rate of myelination is increased. In the absence of NRG or BDNF, 
myelination proceeds independently of activity, but once the switch has occurred, blocking NMDA 
receptors prevents myelination (Lundgaard and others 2013). NRG or BDNF alongside glutamate 
released from active neurons increases NMDA receptor currents in OPCs and the proportion of 
cells with NMDA receptors, indicating that this switch to activity-dependent myelination may 
involve OPCs transitioning into a primed state (Figure 7; alternatively, NRG or BDNF may 
stimulate the generation of a new pool of primed OPCs). Indeed, primed OPCs exhibit high 
densities of NMDA receptors and voltage-gated sodium channels, and thus have a high sensitivity 
to neuronal activity, suggesting that they are the most likely state to be involved in activity-
dependent myelination. 
 
However, this raises many questions. With age, primed OPCs are replaced by a population of 
quiescent cells. Nonetheless, low levels of cortical myelination continue throughout life, and 
myelination can be enhanced in aged mice by specific triggers such as sensory enrichment or 
learning (Hill and others 2018; Hughes and others 2018; Wang and others 2020). What happens 
to quiescent OPCs following these triggers? Does sensory enrichment or learning promote activity-
17 
 
dependent release of NRG or BDNF and promote a transition back into a primed state? 
Alternatively, myelination in aged mice could depend on already existing oligodendrocytes, 
although the sheer number of OPCs present in the CNS throughout adulthood suggests otherwise 
(Bacmeister and others 2020). And what of the naïve OPCs? Are they needed for activity-
independent myelination during the early stages of development? If so, why does a small number 
remain in the postnatal brain? Do they represent a reserve pool of stem cells? Subventricular zone 
OPCs have been shown to migrate into the corpus callosum following toxin-induced 
demyelinating lesions (Menn and others 2006; Etxeberria and others 2010), indicating that this 
may be the case. Alternatively, are naïve OPCs simply an early stage in the lineage? If this were 
the case, all OPCs should be born as naïve, but this remains to be ascertained. 
 
Importantly, other factors beyond NRG have been shown to regulate glutamate receptors and ion 
channels in OPCs (Gallo and others 1994; Chittajallu and others 2005; Zonouzi and others 2011), 
indicating that complex regulation is at play, and that a better understanding of OPC diversity, or 




Myelin repair and cell states 
As developmental OPC cell states or diversity are recapitulated in demyelinating lesions 
undergoing regeneration (Gautier and others 2015; Moyon and others 2015; Falcão and others 
2018), studying OPC diversity, or OPC functional states, may be critical for understanding disease 
progression and developing therapeutic approaches. For instance, OPCs in human chronic MS 
lesions were described as quiescent, as they fail to proliferate or differentiate (Wolswijk 1998). 
Given that the majority of OPCs become quiescent with age, it may be important to focus on this 
state, and examine if it can be pushed to a primed state to promote myelin repair. While a number 
of studies have identified compounds to promote remyelination in white matter demyelinating or 
inflammatory lesions (reviewed by Franklin and ffrench-Constant 2017), most studies focus on 
young animals. Nevertheless, some recent studies have shown that remyelination can be enhanced 
in aged animals by systemic rejuvenation, altering OPC sensitivity to the microenvironment, or 
compounds that act on OPCs and “rejuvenate” them (Ruckh and others 2012; Neumann and others 
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2019; Segel and others 2019), indicating that changes occurring with ageing can be reversed. 
Recently, it was also shown that mature myelinating oligodendrocytes could contribute to 
remyelination (but see Neumann and others 2020), and sequencing mature oligodendrocytes in 
multiple sclerosis brains suggested that they had higher proportions of actively myelinating mature 
oligodendrocytes compared to control brains, indicating that injury may promote a shift to a more 
myelinating state to contribute to repair (Jäkel and others 2019; Yeung and others 2019; 
Bacmeister and others 2020). Identifying which OPC or mature oligodendrocyte states to target 




Increasing evidence suggests that OPCs, and perhaps mature oligodendrocytes, are functionally 
diverse. The convergence of transcriptomic, proteomic and electrophysiological signatures with a 
specific function suggests that this diversity underlies cell states, rather than cell types. 
Nevertheless, these signatures could be interpreted to represent cell types, with specific OPC 
populations perhaps giving rise to specific oligodendrocyte populations. This is currently difficult 
to establish, given the different methodologies used to examine OPC and oligodendrocyte 
diversity. A more cohesive approach may provide more data supporting this hypothesis, but 
nonetheless, it remains unlikely, given the dynamic changes occurring in OPC properties with age, 
while all oligodendrocyte populations are detected in different age ranges, and the shifts in the 
transcriptome of oligodendrocyte lineage cells in disease. Whether this diversity underlies states 
or cell types will determine how oligodendrocyte lineage cells respond to the various cues driving 
lineage progression and myelination, and how these cues can be manipulated to promote myelin 
regeneration. Thus, a better understanding of OPC diversity and whether it represents cell types or 
functional states, and how these states might be regulated, will be crucial to provide insights into 
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Figure 1. Oligodendrocyte lineage cells exhibit distinct antigenic and electrophysiological 
properties 
Summary of the antigenic and electrophysiological properties of oligodendrocyte (OL) lineage 
cells. The top panel displays antigens that are typically used to distinguish OL lineage cells. 
SOX10 and OLIG2 label all oligodendrocyte lineage cells, but oligodendrocyte precursor cells 
(OPCs) are defined by the additional expression of PDGFRα and NG2, while immature OLs can 
be labelled with O4, and myelinating OLs express MOG. However, some antigen markers such as 
O4, GalC, CC1, MBP and PLP can be detected as cells transition between stages in the lineage. 
OL lineage cells have typical electrophysiological profiles (bottom panel) in response to the 
application of voltage steps (boxed, 20mV pulses from -134mV to 26mV applied from a holding 
potential of -74mV). OPCs typically exhibit fast outward voltage-gated potassium currents, 
delayed outward voltage-gated potassium currents and fast inward tetrodotoxin-sensitive voltage-
gated sodium currents (NaV) (left). However, some OPCs lack these voltage-gated ion channels 
(right). Both types of OPCs lack the tail current observed in immature and mature OLs. The two 
insets show leak-subtracted traces of fast inward voltage-gated sodium currents and fast outward 
voltage-gated potassium currents (left), or a lack of voltage-gated currents (right). Immature OLs 
lack voltage-gated currents, but display passive, ohmic, current responses and exhibit tail currents. 
Myelinating OLs display the same properties as immature OLs, but with lower membrane 
resistances. 
 
Figure 2. Oligodendrocyte precursor cell membrane properties alter with age 
Oligodendrocyte precursor cells (OPCs) were voltage-clamped in the cortex and corpus callosum 
of NG2-EYFP mice at different developmental timepoints. (A) Representative leak-subtracted 
traces of fast inward tetrodotoxin-sensitive voltage-gated sodium currents recorded at embryonic 
day 13 (E13), during the first two postnatal weeks (P6-16), and at nine months. Voltage-gated 
sodium currents are not detected at E13, peak in density during the first two postnatal weeks, and 
decrease with age. (B) Representative current responses to the application of 30µM kainate. 
Kainate does not evoke a response at E13, but evokes responses in postnatal OPCs, and the density 
of kainate receptors increases with age. (C) Representative NMDA (60µM)-evoked currents. 
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NMDA currents are not detected at E13 or nine months, but are detected in the first two postnatal 
weeks. (D) Proportion of NG2-EYFP cells with outward voltage-gated potassium channels (KV), 
AMPA/kainate receptors (KAR), voltage-gated sodium channels (NaV) and NMDA receptors 
(NMDAR) between E13 and nine months. At E13, OPCs lack voltage-gated channels and 
glutamate receptors. KV, AMPA/KAR and NaV are first detected at E18, in varying proportions. 
By birth (P0), all OPCs exhibit KV and AMPA/KAR, and the majority of OPCs have NaV. 
NMDAR appear by P0, peak in the first postnatal month, and disappear by nine months. Panels 
A-D are adapted from Spitzer and others, Neuron 2019 (with permission according to a Creative 
Commons Attribution License (CC BY)). 
 
Figure 3. Oligodendrocyte precursor cell states 
Drawing from fields across biology, and correlating transcriptomic, proteomic, single-cell 
electrophysiology and functional data we propose that oligodendrocyte precursor cells (OPCs) 
exist in six distinct functional states. From left to right, first, the naïve OPC, lacking ion channels 
and glutamate receptors, but likely marked by EGFR expression along with cell cycle, neural 
progenitors and transcription factor activity genes. Second, the migratory OPC, marked by voltage-
gated potassium channels (KV), AMPA/kainate receptors (AMPA/KAR), and the expression of 
migratory and cytoskeletal genes. Third, a highly proliferative OPC, marked by KV, AMPA/KAR, 
a high density of voltage-gated sodium channels (NaV), and high expression of cell cycle genes. 
Fourth, a primed OPC, characterised by KV, NaV, AMPA/KAR, NMDA receptors (NMDAR), and 
high levels of differentiation, metabolic, signal transduction and synaptic signalling genes. Fifth, 
a quiescent OPC, marked by a KV, NaV, a high density of AMPA/KAR, a decrease in cell cycle 
genes, and an increased quiescent signature. Sixth, a potential senescent state, marked by an 
increase in Cdkn2a transcript levels and a decrease in ribosome biogenesis. The 
electrophysiological profile of this cell state is not currently known. Cell capacitance varies 
between states; as drawn here, larger cells represent states with a larger cell capacitance, while 
smaller cells have a lower capacitance. The six OPC states of OPCs can be further divided into 
two groups: states with ongoing proliferation, or states in cell cycle arrest/exit, as indicated above 
the depicted states. These states are generally observed as a temporal progression (black arrows), 
but may be reversible (grey arrows), although the extent of and how OPCs transition between 




Figure 4. Oligodendrocyte precursor cell state distribution with age and brain region 
Approximate proportions of each oligodendrocyte precursor cell (OPC) state found in different 
brain regions at different timepoints, as determined by electrophysiology (Spitzer and others 
2019). The proportions represented here are based on the proportion of OPCs with voltage-gated 
ion channels and glutamate receptors as shown in figures 1, 4, and 6 from Spitzer and others 
(2019). At embryonic day 13 (E13), all OPCs are naïve. Postnatally, the proportion of each state 
varies with age and brain region, following function. For instance, the proportion of primed OPCs 
is highest in the cortex and corpus callosum at P30, at the peak of myelination, but remains low in 
OPCs recorded in the cerebellar molecular layer, where there is no myelination.  
 
Figure 5. Single-cell RNA sequencing of oligodendrocytes indicates that they are diverse, and 
altered in experimental autoimmune encephalitis and multiple sclerosis 
t-stochastic neighbour embedding (t-SNE) analysis of single-cell sequencing of oligodendrocyte 
lineage cells suggests that mature oligodendrocytes exhibit diversity. (A) t-SNE projection of 
oligodendrocyte lineage cells in the juvenile and adult posterior forebrain or spinal cord reveals a 
developmental trajectory from oligodendrocyte precursor cells (OPCs) to several mature 
oligodendrocyte (MOL) clusters. VLMC, vascular and leptomeningeal cells; COP, committed 
oligodendrocyte precursor; NFOL, newly formed oligodendrocyte; MFOL, myelin forming 
oligodendrocyte. From Marques and others. 2016. Oligodendrocyte heterogeneity in the mouse 
juvenile and adult central nervous system. Science 352(6291):1326–1329. 
https://science.sciencemag.org/content/352/6291/1326 Reprinted with permission from AAAS. 
(B) t-SNE plot of oligodendrocyte lineage cells sequenced from adult spinal cord in control and 
experimental autoimmune encephalitis (EAE) mice. Cluster identities were based on Marques and 
others 2016. MOL populations differ between control and EAE samples. Reprinted by permission 
from Springer Nature: Nature Research, Nature Medicine. Disease-specific oligodendrocyte 
lineage cells arise in multiple sclerosis. Falcão and others. Copyright © 2018, Springer Nature. 
2018. (C) t-SNE projection of single-nuclei sequencing of white matter oligodendrocyte lineage 
cells from frozen control and multiple sclerosis patient brains. Several mature oligodendrocyte 
clusters were identified, and the proportion of cells in individual clusters is altered in multiple 
sclerosis. Reprinted by permission from Springer Nature: Nature Research, Nature. Altered human 
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oligodendrocyte heterogeneity in multiple sclerosis. Jäkel and others. Copyright © 2019, Springer 
Nature. 2019. (D) Summary table of potential oligodendrocyte states identified from single-cell 
sequencing of murine cells or single-nuclei sequencing of human cells. Both mouse and human 
oligodendrocytes appear to follow a similar progression through functional states, and the 
proportion of cells in individual clusters is altered in both EAE and multiple sclerosis. Further, 
murine and human cell clusters may be correlated: grey dashed lines indicate potential correlations 
between murine and human cell clusters based on transcriptome (Jäkel and others 2019). However, 
differences in species, region, and methodology can make these correlations difficult, and thus, 
these remain tentative. 
 
Figure 6. Possible oligodendrocyte functions – does oligodendrocyte diversity underlie 
functional states? 
Single-cell sequencing studies have identified up to six different myelinating oligodendrocyte 
clusters. Analysis of differential gene expression between these clusters suggests that they may 
represent different stages of myelination, or different functional states. For instance, these clusters 
may underlie oligodendrocytes engaged in sheath elongation or retraction, altering sheath 
thickness in response to neuronal activity-driven vesicle (white circles) release at the axo-myelinic 
synapse, ensheathing an axon, providing metabolic support to an axon (metabolites in green), or 
locating an active axon to myelinate, but this remains to be further determined. 
 
Figure 7. Two modes of myelination: activity-dependent and activity-independent 
myelination 
(A) Schematic diagram of the two modes of myelination and how the switch between them is 
activated. The presence of neuregulin (NRG)/BDNF and active axons, releasing glutamate, 
triggers the switch from activity-independent myelination to activity-dependent myelination, 
where OPCs display increased sensitivity to neuronal activity (increased NMDA currents), and 
myelination occurs faster compared to the default mode. In the absence of either NRG or BDNF 
myelination proceeds via the default program irrespective of activity, however the presence of 
activity and glutamate release is required in addition to the growth factors in order to trigger the 
switch to activity-dependent myelination. (B) Shows some of the data supporting the switch 
between myelination modes in neuron-OPC cocultures. In the absence of NRG, blocking neuronal 
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activity with tetrodotoxin (TTX), NMDA receptors with MK-801 (MK) or both neuronal activity 
and NMDA receptors (TTX MK) does not affect myelination as the switch is not triggered. 
Addition of NRG to cocultures without blocking baseline activity triggers the switch to activity-
dependent myelination. Blockade of NMDA receptors with the open channel antagonist MK-801 
in the presence of NRG reduces myelination to 25% of control levels as the switch to activity 
dependence is triggered, but the activity can no longer be detected by the NMDA receptors. 
Blocking activity with TTX, or blocking both activity and NMDA receptors, in the presence of 
NRG prevents the switch from occurring, demonstrated by similar myelination levels as in the 
absence of NRG. ***p<0.001. (C) Addition of NRG to neuron-OPC cocultures both increases and 
accelerates myelination. (D) In the presence of NRG, NMDA (60µM)-evoked currents increase in 
OPCs, while kainate (30µM)-evoked currents do not change, suggesting an increase in the 
proportion of primed cells. *p<0.05. (E) Representative traces for NMDA- and kainate-evoked 
currents recorded in voltage-clamped OPCs in the presence or absence of NRG. Panels B, C and 
D are adapted from Lundgaard and others, PLOS Biology 2013 (with permission according to a 
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